1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Prostate Cancer Treatment Drugs Markets in China

Prostate Cancer Treatment Drugs Markets in China

  • March 2016
  • -
  • Asia Market Information & Development Company
  • -
  • 244 pages

China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Table Of Contents

Prostate Cancer Treatment Drugs Markets in China
TABLE OF CONTENTS




I.INTRODUCTION

Report Scope and Methodology
Executive Summary

II.BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Prostate Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Prostate Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview
Demand of Prostate Cancer Treatment Drugs by Region
Prostate Cancer Treatment Drugs Sales Volume
Bicalutamide Sales volume and market share
Flutamide Sales volume and market share
Cyproterone Acetate Sales volume and market share
Megestrol Acetate Sales volume and market share
Triptorelin Acetate Sales volume and market share
Goserelin Acetate Sales volume and market share
Leuprorelin Acetate Sales volume and market share
Estramustine disodium phosphate Sales volume and market share
Docetaxel Sales volume and market share
Other Prostate Cancer Treatment Drugs Sales volume and market share
Prostate Cancer Treatment Drugs Imports
Pricing Trends

V. PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK

Prostate Cancer Treatment Drugs Markets Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

Distribution System in China
China's Distribution System
Prostate Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China's Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises


VII. PROSTATE CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Prostate Cancer Treatment Drugs Producer Profiles
Distributors and Trading Companies
Research Institutions and Associations


LIST OF TABLES


I. INTRODUCTION

Economic Outlook Summary
II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Prostate Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Prostate Cancer Treatment Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investments

IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Total Prostate Cancer Treatment Drugs Sales Volume
Prostate Cancer Treatment Drug Major Producer and Their Market Share
Chemotherapeutic Drug Major Producer and Their Market Share
Bicalutamide Major Producer and Their Market Share
Flutamide Major Producer and Their Market Share
Cyproterone Acetate Major Producer and Their Market Share
Megestrol Acetate Major Producer and Their Market Share
Luteinizing Hormone Releasing Hormonr Analogue Major Producer and Their Market Share
Triptorelin Major Producer and Their Market Share
Goserelin Acetate Major Producer and Their Market Share
Leuprorelin Acetate Major Producer and Their Market Share
Estramustine phosphate Major Producer and Their Market Share
Docetaxel Major Producer and Their Market Share
Prostate Cancer Treatment Drugs Import

V.PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK

Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits



LIST OF CHARTS

I. NTRODUCTION

Prostate Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China's GDP and Industrial Output
Industrial Output by Ownership
China's Imports and Exports

III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Prostate Cancer Treatment Drugs Sales Volume
Androgen Receptor Antagonist Sales Volume by Drugs Classification
Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification
Prostate Cancer Treatment Drugs Sales Volume

IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Prostate Cancer Treatment Drugs Sales Volume
Worldwide Prostate Cancer Treatment Drugs Demand by region
Androgen Receptor Antagonist Sales Volume and Market Share
Androgen Receptor Antagonist Sales Volume by Drugs Classification
Bicalutamide Sales Volume and Market Share
Flutamide Sales Volume and Market Share
Cyproterone Acetate Sales Volume and Market Share
Megestrol Acetate Sales Volume and Market Share
Luteinizing Hormone Releasing Hormonr Analogue Sales Volume and Market Share
Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification
Triptorelin Sales Volume and Market Share
Goserelin Acetate Sales Volume and Market Share
Leuprorelin Acetate Sales Volume and Market Share
Estramustine phosphate Sales Volume and Market Share
Docetaxel Sales Volume and Market Share
Other Prostate Cancer Treatment Drugs Sales Volume and Market Share
Prostate Cancer Treatment Drugs Import Volume
Androgen Receptor Antagonist Import and Market Share
Androgen Receptor Antagonist Import by Drugs Classification
Bicalutamide Import Volume and Market Share
Flutamide Import Volume and Market Share
Cyproterone Acetate Import Volume and Market Share
Megestrol Acetate Import Volume and Market Share
Luteinizing Hormone Releasing Hormone Analogue Import Volume and Market Share
Luteinizing Hormone Releasing Hormone Analogue Import by Drugs Classification
Leuprorelin Acetate Import Volume and Market Share
Triptorelin Import Volume and Market Share
Goserelin Acetate Import Volume and Market Share
Estramustine phosphate Import Volume and Market Share
Docetaxel Import Volume and Market Share
Other Import Volume and Market Share

V.PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK

Prostate Cancer Treatment Drugs Sales Volume

VI. MARKETING STRATEGIES

China's Distribution Channel

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

  • $ 34500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Insulin Market and Diabetes Statistics in the US

  • January 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Therapy Market

  • January 2017
    19 pages
  • Therapy  

    Anticoagulant  

    Cancer  

View report >

Related Market Segments :

Hormone
Pharmaceutical
Prostate Cancer

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.